Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling

This publication has 25 references indexed in Scilit:

• Neuroprotective Effects of a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, 2-{3-[4-(4-Chlorophenyl)-1-piperazinyl] propyl}-4(3 H)-quinazolinone (FR255595), in an in Vitro Model of Cell Death and in Mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson’s Disease
  The Journal of Pharmacology and Experimental Therapeutics, 2004
• Crystal structure of the catalytic fragment of murine poly(ADP-ribose) polymerase-2
  Nucleic Acids Research, 2004
• Inhibitor‐induced structural change of the active site of human poly(ADP‐ribose) polymerase
  FEBS Letters, 2003
• Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
  Science, 2002
• PARP-2, A Novel Mammalian DNA Damage-dependent Poly(ADP-ribose) Polymerase
  Journal of Biological Chemistry, 1999
• Poly(ADP-ribose) Polymerase Null Mouse Cells Synthesize ADP-ribose Polymers
  Journal of Biological Chemistry, 1998
• Role of poly(ADP-ribose) synthetase in inflammation and ischaemia–reperfusion
  Trends in Pharmacological Sciences, 1998
• Inhibitor and NAD⁺ Binding to Poly(ADP-ribose) Polymerase As Derived from Crystal Structures and Homology Modeling^,
  Biochemistry, 1998
• Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken.
  Proceedings of the National Academy of Sciences, 1996
• Structure and function of poly(ADP-ribose) polymerase
  Molecular and Cellular Biochemistry, 1994